Cravath’s New York Office Moves to Two Manhattan West
Maggie Segall is a member of the Antitrust Practice. Her practice focuses on transactional matters, antitrust regulatory approval, government investigations, including civil conduct investigations brought by both federal and state antitrust authorities, as well as general antitrust counseling and critical antitrust litigation. She has advised a wide variety of clients in diverse industries, including aerospace and aviation, pharmaceuticals, life sciences, consumer products, media, manufacturing and technology.
Ms. Segall has represented clients on antitrust issues in connection with numerous proposed or completed deals. These representations include:
Altra Industrial’s $5 billion acquisition by Regal Rexnord;
RWE AG’s $6.8 billion acquisition of Con Edison Clean Energy Businesses;
ADT’s $1.2 billion equity investment from State Farm;
Micro Focus’s $6 billion acquisition by OpenText;
Global Blood Therapeutics’s $5.4 billion acquisition by Pfizer;
In addition, Ms. Segall regularly handles civil conduct investigations and complex antitrust litigation. Some of her recent and notable litigations include:
Ms. Segall has been repeatedly recognized for her antitrust work by Chambers USA and The Legal 500 US, including being recommended as a “Leading Lawyer” for antitrust merger control. She has been named to Crain’s New York Business’s list of “Notable Women in Law,” and Lawdragon’s lists of “500 Leading Global Antitrust & Competition Lawyers” and “500 Leading Litigators in America.” In addition to her inclusion in Bloomberg Law’s and Global Competition Review’s “40 Under 40” lists, Benchmark Litigation has included Ms. Segall on its “40 & Under List” and consistently recognized her as a “Future Star.”
Among other accolades, Who’s Who Legal has previously recommended Ms. Segall for her antitrust work, including naming her the “Most Highly Regarded Future Leader” in Competition in North America. Ms. Segall was also recognized for her antitrust work by LMG Life Sciences, and she has received Euromoney Legal Media Group’s Rising Star Award for “Best in Antitrust/Competition.” She was additionally recognized as one of Law360’s “Rising Stars” in Competition.
Ms. Segall is a Fellow of the American Bar Foundation and a member of the Antitrust Sections for the American Bar Association, New York State Bar Association and International Bar Association, where she also serves as a Publications Officer.
Ms. Segall was born in Ann Arbor, Michigan. She received an A.B. magna cum laude from Harvard College in 2003, where she concentrated in History. She received a J.D. cum laude from Harvard Law School in 2008, where she was a member of the Board of Student Advisors and the International Law Journal and the president of Harvard Law School’s wine appreciation society.
Ms. Segall joined Cravath in 2008 and was elected a partner in 2016. She currently serves as Litigation Hiring Partner and is a member of the Diversity Committee.
Ms. Segall has represented clients on antitrust issues in connection with numerous proposed or completed deals. These representations include:
Altra Industrial’s $5 billion acquisition by Regal Rexnord;
RWE AG’s $6.8 billion acquisition of Con Edison Clean Energy Businesses;
ADT’s $1.2 billion equity investment from State Farm;
Micro Focus’s $6 billion acquisition by OpenText;
Global Blood Therapeutics’s $5.4 billion acquisition by Pfizer;
In addition, Ms. Segall regularly handles civil conduct investigations and complex antitrust litigation. Some of her recent and notable litigations include:
Ms. Segall has been repeatedly recognized for her antitrust work by Chambers USA and The Legal 500 US, including being recommended as a “Leading Lawyer” for antitrust merger control. She has been named to Crain’s New York Business’s list of “Notable Women in Law,” and Lawdragon’s lists of “500 Leading Global Antitrust & Competition Lawyers” and “500 Leading Litigators in America.” In addition to her inclusion in Bloomberg Law’s and Global Competition Review’s “40 Under 40” lists, Benchmark Litigation has included Ms. Segall on its “40 & Under List” and consistently recognized her as a “Future Star.”
Among other accolades, Who’s Who Legal has previously recommended Ms. Segall for her antitrust work, including naming her the “Most Highly Regarded Future Leader” in Competition in North America. Ms. Segall was also recognized for her antitrust work by LMG Life Sciences, and she has received Euromoney Legal Media Group’s Rising Star Award for “Best in Antitrust/Competition.” She was additionally recognized as one of Law360’s “Rising Stars” in Competition.
Ms. Segall is a Fellow of the American Bar Foundation and a member of the Antitrust Sections for the American Bar Association, New York State Bar Association and International Bar Association, where she also serves as a Publications Officer.
Ms. Segall was born in Ann Arbor, Michigan. She received an A.B. magna cum laude from Harvard College in 2003, where she concentrated in History. She received a J.D. cum laude from Harvard Law School in 2008, where she was a member of the Board of Student Advisors and the International Law Journal and the president of Harvard Law School’s wine appreciation society.
Ms. Segall joined Cravath in 2008 and was elected a partner in 2016. She currently serves as Litigation Hiring Partner and is a member of the Diversity Committee.
American Bar Foundation
American Bar Association
International Bar Association
New York State Bar Association
Benchmark Litigation
Bloomberg Law
Chambers USA
Crain’s New York Business
Global Competition Review
Euromoney Legal Media Group
Law360
Lawdragon
The Legal 500 US
Super Lawyers - New York
Who’s Who Legal
Americas Rising Star Awards - Best in Antitrust/Competition, Euromoney Legal Media Group (2018)
Deals & Cases
January 29, 2025
On January 29, 2025, Dowlais Group plc (“Dowlais”), a specialist engineering group focused on the automotive sector, and American Axle & Manufacturing Holdings, Inc. (“AAM”), a leading automotive and mobility supplier, announced that their boards have reached agreement on the terms of a recommended cash and share combination. Under the terms of the combination, each Dowlais shareholder will be entitled to receive 0.0863 new AAM shares, 42 pence in cash and up to 2.8 pence in the form of dividends to be paid prior to completion. Dowlais shareholders will own approximately 49% of AAM upon closing. The offer values Dowlais at approximately £1.16 billion.
Deals & Cases
January 28, 2025
On January 28, 2025, Paragon 28, Inc. (“Paragon 28”), a leading medical device company focused on the foot and ankle orthopedic segment, and Zimmer Biomet Holdings, Inc. (“Zimmer Biomet”), a global medical technology leader, announced they have entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of common stock of Paragon 28 for an upfront payment of $13.00 per share in cash, corresponding to an equity value of approximately $1.1 billion and an enterprise value of approximately $1.2 billion. Paragon 28 shareholders will also receive a non-tradeable contingent value right (CVR) entitling the holder to receive up to $1.00 per share in cash if certain revenue milestones are achieved. Cravath is representing Paragon 28 in connection with the transaction.
Deals & Cases
November 13, 2024
On November 13, 2024, Just Eat Takeaway.com N.V. (“Just Eat Takeaway.com”), one of the world’s leading global online food delivery companies, announced that it has entered into a definitive agreement to sell Grubhub Inc. (“Grubhub”) to Wonder Group, Inc. (“Wonder”) for an enterprise value of $650 million. Grubhub will be transferred with its $500 million of senior notes. Cravath is representing Just Eat Takeaway.com in connection with the transaction.
Deals & Cases
October 07, 2024
On October 4, 2024, Vista Outdoor Inc. (“Vista Outdoor”), the parent company of more than three dozen renowned brands that design, manufacture and market sporting and outdoor products, announced it has entered into a definitive agreement with funds managed by Strategic Value Partners, LLC, and its affiliates (“SVP”), a global alternative investment firm with approximately $19 billion of assets under management, to sell Revelyst in an all‑cash transaction based on an enterprise value of $1.125 billion. In connection with the SVP Transaction, Vista Outdoor also entered into an amendment to the merger agreement with Czechoslovak Group a.s. (“CSG”) to acquire The Kinetic Group, increasing the purchase price for The Kinetic Group to $2.225 billion. Together, the CSG Transaction and the SVP Transaction represent an enterprise value of $3.35 billion for Vista Outdoor and will deliver an estimated $45 per share in cash to Vista Outdoor stockholders. Cravath is representing Vista Outdoor in connection with the transaction.
Deals & Cases
February 28, 2024
On February 28, 2024, Viatris Inc. (“Viatris”), a global healthcare company, and Idorsia Ltd (“Idorsia”) announced they have entered into agreements for a significant global research and development collaboration under which Viatris will receive exclusive global development and commercialization rights to two Phase 3 assets as well as the potential to add additional innovative assets in the future.
Publications
February 11, 2025
Cravath partners G.J. Ligelis Jr., Alyssa K. Caples, Christopher K. Fargo and Margaret T. Segall co‑authored the U.S. Law & Practice chapter of the fifth edition of Chambers “Investing In… 2025” Guide, which was published in January 2025. The guide, which is part of the publisher’s Global Practice Guides series, examines country‑specific legal issues that arise from foreign direct investment (“FDI”) and cross‑border transactions in the more than 30 jurisdictions covered. The U.S. Law & Practice chapter surveys the legal system and regulatory framework for FDI in the country, analyzing the economic climate, as well as considerations related to mergers and acquisitions, corporate governance, capital markets, antitrust, national security, tax, employment and intellectual property.
Activities
February 03, 2025
Cravath partners Noah J. Phillips, Margaret T. Segall and Andrew C. Finch participated in the Global Competition Review Live: Law Leaders Global 2025 program, which was held from January 29‑31, 2025, in Miami, Florida. Noah and Maggie interviewed Rebekah Jurata, General Counsel at American Investment Council, in a fireside chat about how antitrust enforcers have approached private equity – and what to expect under the new Trump Administration. Andrew spoke on a panel entitled “Antitrust: Exchange of competitively sensitive information: how much should we care about sharing?,” during which panelists discussed the limits and framework of cooperation between competitors in light of the European Commission and the Competition and Markets Authority’s new guidance, the withdrawal by the U.S. DOJ of its information sharing guidance and changes in the enforcement landscape as it relates to the exchange of competitively sensitive information.
Activities
November 14, 2024
On October 24, 2024, Cravath hosted its sixth annual Global Enforcement Forum at its offices in New York. The event brought together investigations and regulatory lawyers from the Firm and leading foreign firms across the globe for a series of panel discussions and roundtables examining significant developments in enforcement.
Publications
October 17, 2024
On October 15, 2024, Cravath prepared a memo for its clients entitled “FTC Issues Final HSR Rules.” The memo examines the Federal Trade Commission and the Department of Justice Antitrust Division’s final version of the new Hart‑Scott‑Rodino (HSR) rules, which modify the initial proposed rules released in June 2023. The memo summarizes the HSR rules, which require parties to inform the agencies of proposed acquisitions through a filing process, including notable changes from the current and proposed rules and their implications for filing parties.
Activities
September 23, 2024
Cravath partners Alyssa K. Caples, Margaret T. Segall, Nicholas A. Dorsey, C. Daniel Haaren and Bethany A. Pfalzgraf spoke at the International Bar Association’s 2024 Annual Conference, which was held September 15‑20 in Mexico City and convened legal professionals from across the globe.
Maggie Segall is a member of the Antitrust Practice. Her practice focuses on transactional matters, antitrust regulatory approval, government investigations, including civil conduct investigations brought by both federal and state antitrust authorities, as well as general antitrust counseling and critical antitrust litigation. She has advised a wide variety of clients in diverse industries, including aerospace and aviation, pharmaceuticals, life sciences, consumer products, media, manufacturing and technology.
Ms. Segall has represented clients on antitrust issues in connection with numerous proposed or completed deals. These representations include:
Altra Industrial’s $5 billion acquisition by Regal Rexnord;
RWE AG’s $6.8 billion acquisition of Con Edison Clean Energy Businesses;
ADT’s $1.2 billion equity investment from State Farm;
Micro Focus’s $6 billion acquisition by OpenText;
Global Blood Therapeutics’s $5.4 billion acquisition by Pfizer;
In addition, Ms. Segall regularly handles civil conduct investigations and complex antitrust litigation. Some of her recent and notable litigations include:
Ms. Segall has been repeatedly recognized for her antitrust work by Chambers USA and The Legal 500 US, including being recommended as a “Leading Lawyer” for antitrust merger control. She has been named to Crain’s New York Business’s list of “Notable Women in Law,” and Lawdragon’s lists of “500 Leading Global Antitrust & Competition Lawyers” and “500 Leading Litigators in America.” In addition to her inclusion in Bloomberg Law’s and Global Competition Review’s “40 Under 40” lists, Benchmark Litigation has included Ms. Segall on its “40 & Under List” and consistently recognized her as a “Future Star.”
Among other accolades, Who’s Who Legal has previously recommended Ms. Segall for her antitrust work, including naming her the “Most Highly Regarded Future Leader” in Competition in North America. Ms. Segall was also recognized for her antitrust work by LMG Life Sciences, and she has received Euromoney Legal Media Group’s Rising Star Award for “Best in Antitrust/Competition.” She was additionally recognized as one of Law360’s “Rising Stars” in Competition.
Ms. Segall is a Fellow of the American Bar Foundation and a member of the Antitrust Sections for the American Bar Association, New York State Bar Association and International Bar Association, where she also serves as a Publications Officer.
Ms. Segall was born in Ann Arbor, Michigan. She received an A.B. magna cum laude from Harvard College in 2003, where she concentrated in History. She received a J.D. cum laude from Harvard Law School in 2008, where she was a member of the Board of Student Advisors and the International Law Journal and the president of Harvard Law School’s wine appreciation society.
Ms. Segall joined Cravath in 2008 and was elected a partner in 2016. She currently serves as Litigation Hiring Partner and is a member of the Diversity Committee.
Ms. Segall has represented clients on antitrust issues in connection with numerous proposed or completed deals. These representations include:
Altra Industrial’s $5 billion acquisition by Regal Rexnord;
RWE AG’s $6.8 billion acquisition of Con Edison Clean Energy Businesses;
ADT’s $1.2 billion equity investment from State Farm;
Micro Focus’s $6 billion acquisition by OpenText;
Global Blood Therapeutics’s $5.4 billion acquisition by Pfizer;
In addition, Ms. Segall regularly handles civil conduct investigations and complex antitrust litigation. Some of her recent and notable litigations include:
Ms. Segall has been repeatedly recognized for her antitrust work by Chambers USA and The Legal 500 US, including being recommended as a “Leading Lawyer” for antitrust merger control. She has been named to Crain’s New York Business’s list of “Notable Women in Law,” and Lawdragon’s lists of “500 Leading Global Antitrust & Competition Lawyers” and “500 Leading Litigators in America.” In addition to her inclusion in Bloomberg Law’s and Global Competition Review’s “40 Under 40” lists, Benchmark Litigation has included Ms. Segall on its “40 & Under List” and consistently recognized her as a “Future Star.”
Among other accolades, Who’s Who Legal has previously recommended Ms. Segall for her antitrust work, including naming her the “Most Highly Regarded Future Leader” in Competition in North America. Ms. Segall was also recognized for her antitrust work by LMG Life Sciences, and she has received Euromoney Legal Media Group’s Rising Star Award for “Best in Antitrust/Competition.” She was additionally recognized as one of Law360’s “Rising Stars” in Competition.
Ms. Segall is a Fellow of the American Bar Foundation and a member of the Antitrust Sections for the American Bar Association, New York State Bar Association and International Bar Association, where she also serves as a Publications Officer.
Ms. Segall was born in Ann Arbor, Michigan. She received an A.B. magna cum laude from Harvard College in 2003, where she concentrated in History. She received a J.D. cum laude from Harvard Law School in 2008, where she was a member of the Board of Student Advisors and the International Law Journal and the president of Harvard Law School’s wine appreciation society.
Ms. Segall joined Cravath in 2008 and was elected a partner in 2016. She currently serves as Litigation Hiring Partner and is a member of the Diversity Committee.
American Bar Foundation
American Bar Association
International Bar Association
New York State Bar Association
Benchmark Litigation
Bloomberg Law
Chambers USA
Crain’s New York Business
Global Competition Review
Euromoney Legal Media Group
Law360
Lawdragon
The Legal 500 US
Super Lawyers - New York
Who’s Who Legal
Americas Rising Star Awards - Best in Antitrust/Competition, Euromoney Legal Media Group (2018)
Deals & Cases
January 29, 2025
On January 29, 2025, Dowlais Group plc (“Dowlais”), a specialist engineering group focused on the automotive sector, and American Axle & Manufacturing Holdings, Inc. (“AAM”), a leading automotive and mobility supplier, announced that their boards have reached agreement on the terms of a recommended cash and share combination. Under the terms of the combination, each Dowlais shareholder will be entitled to receive 0.0863 new AAM shares, 42 pence in cash and up to 2.8 pence in the form of dividends to be paid prior to completion. Dowlais shareholders will own approximately 49% of AAM upon closing. The offer values Dowlais at approximately £1.16 billion.
Deals & Cases
January 28, 2025
On January 28, 2025, Paragon 28, Inc. (“Paragon 28”), a leading medical device company focused on the foot and ankle orthopedic segment, and Zimmer Biomet Holdings, Inc. (“Zimmer Biomet”), a global medical technology leader, announced they have entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of common stock of Paragon 28 for an upfront payment of $13.00 per share in cash, corresponding to an equity value of approximately $1.1 billion and an enterprise value of approximately $1.2 billion. Paragon 28 shareholders will also receive a non-tradeable contingent value right (CVR) entitling the holder to receive up to $1.00 per share in cash if certain revenue milestones are achieved. Cravath is representing Paragon 28 in connection with the transaction.
Deals & Cases
November 13, 2024
On November 13, 2024, Just Eat Takeaway.com N.V. (“Just Eat Takeaway.com”), one of the world’s leading global online food delivery companies, announced that it has entered into a definitive agreement to sell Grubhub Inc. (“Grubhub”) to Wonder Group, Inc. (“Wonder”) for an enterprise value of $650 million. Grubhub will be transferred with its $500 million of senior notes. Cravath is representing Just Eat Takeaway.com in connection with the transaction.
Deals & Cases
October 07, 2024
On October 4, 2024, Vista Outdoor Inc. (“Vista Outdoor”), the parent company of more than three dozen renowned brands that design, manufacture and market sporting and outdoor products, announced it has entered into a definitive agreement with funds managed by Strategic Value Partners, LLC, and its affiliates (“SVP”), a global alternative investment firm with approximately $19 billion of assets under management, to sell Revelyst in an all‑cash transaction based on an enterprise value of $1.125 billion. In connection with the SVP Transaction, Vista Outdoor also entered into an amendment to the merger agreement with Czechoslovak Group a.s. (“CSG”) to acquire The Kinetic Group, increasing the purchase price for The Kinetic Group to $2.225 billion. Together, the CSG Transaction and the SVP Transaction represent an enterprise value of $3.35 billion for Vista Outdoor and will deliver an estimated $45 per share in cash to Vista Outdoor stockholders. Cravath is representing Vista Outdoor in connection with the transaction.
Deals & Cases
February 28, 2024
On February 28, 2024, Viatris Inc. (“Viatris”), a global healthcare company, and Idorsia Ltd (“Idorsia”) announced they have entered into agreements for a significant global research and development collaboration under which Viatris will receive exclusive global development and commercialization rights to two Phase 3 assets as well as the potential to add additional innovative assets in the future.
Publications
February 11, 2025
Cravath partners G.J. Ligelis Jr., Alyssa K. Caples, Christopher K. Fargo and Margaret T. Segall co‑authored the U.S. Law & Practice chapter of the fifth edition of Chambers “Investing In… 2025” Guide, which was published in January 2025. The guide, which is part of the publisher’s Global Practice Guides series, examines country‑specific legal issues that arise from foreign direct investment (“FDI”) and cross‑border transactions in the more than 30 jurisdictions covered. The U.S. Law & Practice chapter surveys the legal system and regulatory framework for FDI in the country, analyzing the economic climate, as well as considerations related to mergers and acquisitions, corporate governance, capital markets, antitrust, national security, tax, employment and intellectual property.
Activities
February 03, 2025
Cravath partners Noah J. Phillips, Margaret T. Segall and Andrew C. Finch participated in the Global Competition Review Live: Law Leaders Global 2025 program, which was held from January 29‑31, 2025, in Miami, Florida. Noah and Maggie interviewed Rebekah Jurata, General Counsel at American Investment Council, in a fireside chat about how antitrust enforcers have approached private equity – and what to expect under the new Trump Administration. Andrew spoke on a panel entitled “Antitrust: Exchange of competitively sensitive information: how much should we care about sharing?,” during which panelists discussed the limits and framework of cooperation between competitors in light of the European Commission and the Competition and Markets Authority’s new guidance, the withdrawal by the U.S. DOJ of its information sharing guidance and changes in the enforcement landscape as it relates to the exchange of competitively sensitive information.
Activities
November 14, 2024
On October 24, 2024, Cravath hosted its sixth annual Global Enforcement Forum at its offices in New York. The event brought together investigations and regulatory lawyers from the Firm and leading foreign firms across the globe for a series of panel discussions and roundtables examining significant developments in enforcement.
Publications
October 17, 2024
On October 15, 2024, Cravath prepared a memo for its clients entitled “FTC Issues Final HSR Rules.” The memo examines the Federal Trade Commission and the Department of Justice Antitrust Division’s final version of the new Hart‑Scott‑Rodino (HSR) rules, which modify the initial proposed rules released in June 2023. The memo summarizes the HSR rules, which require parties to inform the agencies of proposed acquisitions through a filing process, including notable changes from the current and proposed rules and their implications for filing parties.
Activities
September 23, 2024
Cravath partners Alyssa K. Caples, Margaret T. Segall, Nicholas A. Dorsey, C. Daniel Haaren and Bethany A. Pfalzgraf spoke at the International Bar Association’s 2024 Annual Conference, which was held September 15‑20 in Mexico City and convened legal professionals from across the globe.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.